406 related articles for article (PubMed ID: 4064045)
1. The cytologic application of carcinoembryonic antigen for the discrimination of malignant from benign serous effusions.
Kyrkou KA; Iatridis SG; Athanassiadou PP; Athanassiadis PP; Mandragos CE
Cancer Detect Prev; 1985; 8(1-2):247-54. PubMed ID: 4064045
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
3. Value of human chorionic gonadotropin compared to CEA in discriminating benign from malignant effusions.
Lamerz R; Stoetzer OJ; Mezger J; Brandt A; Darsow M; Wilmanns W
Anticancer Res; 1999; 19(4A):2421-5. PubMed ID: 10470169
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic significance of carcinoembryonic antigen levels in serous effusions. Correlation with cytology.
Whiteside TL; Dekker A
Acta Cytol; 1979; 23(6):443-8. PubMed ID: 295160
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of carcinoembryonic antigen assay of pleural & peritoneal effusions in malignancy.
Gandhi AK; Nayar M; Bihari N; Chandra M
Indian J Med Res; 1989 Feb; 90():22-6. PubMed ID: 2722212
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical differentiation of reactive mesothelial cells and adenocarcinoma cells in serous effusions with the use of carcinoembryonic antigen and fibronectin.
Athanassiadou P; Athanassiades P; Lazaris D; Kyrkou K; Petrakakou E; Aravantinos D
Acta Cytol; 1994; 38(5):718-22. PubMed ID: 8091904
[TBL] [Abstract][Full Text] [Related]
7. [Carcinoembryonic antigen in ascites and pleural effusions].
Lirzin P; Zeitoun P; Vandromme L; Salas H
Gastroenterol Clin Biol; 1984 Mar; 8(3):222-7. PubMed ID: 6714557
[TBL] [Abstract][Full Text] [Related]
8. Immunoperoxidase demonstration of carcinoembryonic antigen in pleural and peritoneal effusions.
Sehested M; Ralfkjaer E; Rasmussen J
Acta Cytol; 1983; 27(2):124-7. PubMed ID: 6340401
[TBL] [Abstract][Full Text] [Related]
9. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion].
Su XY; Li GD; Liu HB; Jiang LL
Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932
[TBL] [Abstract][Full Text] [Related]
10. The value of the immunoperoxidase slide assay in the diagnosis of malignant pleural effusions in breast cancer.
Guzman J; Costabel U; Bross KJ; Wiehle U; Grunert F; Schaefer HE
Acta Cytol; 1988; 32(2):188-92. PubMed ID: 3279712
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic value of the determination of carcinoembryonic antigens with monoclonal antibodies in abdominal and pleural effusion].
Fei XF
Zhonghua Jie He He Hu Xi Za Zhi; 1990 Feb; 13(1):28-9, 62. PubMed ID: 2379252
[TBL] [Abstract][Full Text] [Related]
12. [Oncologic diagnosis of serous effusions in body cavities (cytologic study and evaluation of cholesterol and carcinoembryonic antigen levels)].
Gulyás M; Elek G; Molnár M; Szollár L
Orv Hetil; 1995 Nov; 136(45):2453-8. PubMed ID: 8524550
[TBL] [Abstract][Full Text] [Related]
13. [Differential diagnosis of pleural effusions].
Ogino M; Koike K; Satoh K; Arai K
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1770-4. PubMed ID: 6476843
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of the diagnostic value of telomerase activity with CEA level in benign and malignant pleural effusions].
Yang Z; Xie C
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Apr; 24(4):201-3. PubMed ID: 11802962
[TBL] [Abstract][Full Text] [Related]
15. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
Afify A; Lynne LC; Howell L
Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576
[TBL] [Abstract][Full Text] [Related]
16. Carcinoembryonic antigen (CEA) levels in pleural effusions and sera of lung cancer patients.
Ogushi F; Fukuoka M; Takada M; Tamai S; Sakai N; Negoro S; Okunaka N; Sone S; Tsubura E
Jpn J Clin Oncol; 1984 Sep; 14(3):321-7. PubMed ID: 6090732
[TBL] [Abstract][Full Text] [Related]
17. Detection of benign or malignant origin of ascites with combined indirect immunoperoxidase assays of carcinoembryonic antigen and lysozyme.
Kyrkou KA; Iatridis SG; Athanassiadou PP; Emmanouilidou AG; Athanassiadis PP
Acta Cytol; 1985; 29(1):57-62. PubMed ID: 3881880
[TBL] [Abstract][Full Text] [Related]
18. Morphometric differences between cytologically benign and malignant serous effusions.
Gavin FM; Gray C; Sutton J; Clayden AD; Banks RI; Bird CC
Acta Cytol; 1988; 32(2):175-82. PubMed ID: 2450434
[TBL] [Abstract][Full Text] [Related]
19. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
20. Specific tumor markers in diagnostic cytology. Immunoperoxidase studies of carcinoembryonic antigen, lysozyme and other tissue antigens in effusions, washes and aspirates.
Walts AE; Said JW
Acta Cytol; 1983; 27(4):408-16. PubMed ID: 6410636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
